Tag: MEMBRANE
J&J MedTech receives US FDA approval for Trufill n‑BCA liquid embolic...
Today, Johnson & Johnson (J&J) MedTech announced that the US Food and Drug Administration (FDA) has approved an expanded indication for the Trufill n‑BCA liquid...
Procedural choices matter but vascular penetration has minimal impact on MMAe...
Sub-analyses of two randomised controlled trials (RCTs) have found that, while the extent of vascular penetration appears to have a minimal bearing on outcomes,...
J&J highlights neurovascular advances at ESMINT 2025 following CE-mark approval for...
Johnson & Johnson (J&J) MedTech highlighted its latest clinical and technological advancements recently at the European Society of Minimally Invasive Neurological Therapy (ESMINT) annual congress...
MEMBRANE becomes latest RCT to demonstrate MMA embolisation’s benefits in cSDH...
The MEMBRANE randomised controlled trial (RCT)—presented at the 2024 Society of Vascular and Interventional Neurology (SVIN) annual meeting (20–22 November, San Diego, USA) by...
Late-breaking data, SLICE collaboration and US$100,000 innovation prize on agenda for...
“This meeting is more than just a conference—it’s a community. And it’s dedicated to pushing the boundaries of what’s possible in the neurovascular space,”...
